OrthoPediatrics (KIDS) Reports Q3 Loss, Tops Revenue Estimates
Portfolio Pulse from
OrthoPediatrics (KIDS) reported a Q3 loss of $0.18 per share, which was larger than the Zacks Consensus Estimate of a $0.12 loss. However, the company exceeded revenue expectations.
November 07, 2024 | 12:15 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
OrthoPediatrics reported a larger-than-expected loss per share for Q3, but managed to surpass revenue estimates. This mixed result may lead to short-term volatility in the stock price.
The larger-than-expected loss per share could negatively impact investor sentiment, but the revenue beat may offset some concerns, leading to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100